Evoke Wealth’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-56,175
Closed -$558K 696
2025
Q3
$558K Sell
56,175
-1,245
-2% -$13K 0.01% 333
2025
Q2
$570K Sell
57,420
-1,875
-3% -$19.8K 0.01% 322
2025
Q1
$769K Buy
59,295
+901
+2% +$11.9K 0.02% 219
2024
Q4
$746K Sell
58,394
-10
-0% -$121 0.02% 208
2024
Q3
$651K Buy
58,404
+31,279
+115% +$345K 0.02% 223
2024
Q2
$305K Buy
+27,125
New +$316K 0.36% 55
2023
Q1
Sell
-58,404
Closed -$621K 359
2022
Q4
$621K Hold
58,404
0.02% 199
2022
Q3
$610K Hold
58,404
0.02% 195
2022
Q2
$735K Buy
58,404
+22,500
+63% +$239K 0.03% 185
2022
Q1
$389K Sell
35,904
-135
-0.4% -$1.64K 0.01% 253
2021
Q4
$507K Buy
36,039
+135
+0.4% +$2.22K 0.02% 239
2021
Q3
$689K Buy
35,904
+1,300
+4% +$17.3K 0.03% 201
2021
Q2
$341K Hold
34,604
0.01% 282
2021
Q1
$340K Hold
34,604
0.02% 248
2020
Q4
$154K Hold
34,604
0.01% 257
2020
Q3
$149K Hold
34,604
0.01% 237
2020
Q2
$307K Hold
34,604
0.03% 149
2020
Q1
$122K Hold
34,604
0.02% 234
2019
Q4
$198K Hold
34,604
0.03% 221
2019
Q3
$124K Buy
+34,604
New +$134K 0.02% 333

Other funds holding DVAX

Evoke Wealth's DVAX Position: Q4 2025 in Review

Evoke Wealth sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 56,175 shares — an estimated $558K sold.

Evoke Wealth first reported a position in DVAX in Q3 2019 and held it in 20 quarters. The position peaked at $769K in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Evoke Wealth reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Evoke Wealth sold 56,175 Dynavax Technologies shares in Q4 2025, an estimated $558K.
  • Evoke Wealth first reported a position in Dynavax Technologies in Q3 2019 and held it in 20 quarters.
  • Evoke Wealth's Dynavax Technologies position peaked at $769K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Evoke Wealth's 13F filing for Q4 2025, filed 6 Feb 2026.